COVID-19 and cell therapy: an interview with Daniel Weiss

Written by Freya Leask

computer-generated image of a virus

In this interview, conducted at ISCT 2020, Daniel Weiss, Professor, Medicine in Pulmonary Disease and Critical Care, University of Vermont (VT, USA) and Chief Scientific Officer, International Society for Cellular Therapy (ISCT), discusses the challenges of developing a cell therapy for COVID-19. Why did you decide to kick the meeting off with an in-depth focus on COVID-19? I think it’s inescapable. We’re living in a world that has been profoundly, probably irrevocably, changed by the COVID-19 pandemic. From a scientific standpoint, with respect to the ISCT, we’re certainly going to cover the range of topics that we would have covered...

To view this content, please register now for access

It's completely free